Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China flag China · Delayed Price · Currency is CNY
21.92
+0.08 (0.37%)
Feb 4, 2026, 10:15 AM CST

SHE:002393 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
1,3161,3321,1451,1411,0871,138
Other Revenue
4.014.017.76.054.672.71
1,3201,3361,1531,1471,0921,141
Revenue Growth (YoY)
4.30%15.88%0.56%5.00%-4.29%-29.37%
Cost of Revenue
590.41624.04487.97510.51473.95456.5
Gross Profit
729.25712.11665.06636.08618684.34
Selling, General & Admin
505.93494.08424.61448.45466.29547.43
Research & Development
118.54122.1102.48102.26100.8273.3
Other Operating Expenses
18.4220.1919.6424.122.3323.25
Operating Expenses
642.57636.39546.47575.03589.34644.05
Operating Income
86.6875.72118.661.0528.6640.29
Interest Expense
-2.88-2.66-0.75-0.88-0.32-0.53
Interest & Investment Income
395.79147.3176.0391.93106.8544.65
Currency Exchange Gain (Loss)
0.010.010.010.11-0.06-0.07
Other Non Operating Income (Expenses)
-14.1-0.72.23-2.16-0.18-0.62
EBT Excluding Unusual Items
465.51219.69196.12150.05134.9583.73
Merger & Restructuring Charges
-6.31-6.31-4.99---
Gain (Loss) on Sale of Investments
3.992.90.620.28--
Gain (Loss) on Sale of Assets
0.19-0.1238.7-34.82--
Asset Writedown
-16.77-0.56-15.27-1.2-1.61-60.24
Other Unusual Items
0.330.335.024.053.787.44
Pretax Income
446.94215.95420.21118.36137.1230.93
Income Tax Expense
55.0229.9958.3924.7615.0122.32
Earnings From Continuing Operations
391.91185.96361.8393.61122.118.62
Minority Interest in Earnings
-5.89-1.43----
Net Income
386.02184.53361.8393.61122.118.62
Net Income to Common
386.02184.53361.8393.61122.118.62
Net Income Growth
104.88%-49.00%286.54%-23.34%1317.31%-95.42%
Shares Outstanding (Basic)
257256258257255241
Shares Outstanding (Diluted)
257256258257255241
Shares Change (YoY)
-0.19%-0.83%0.58%0.71%5.72%-5.63%
EPS (Basic)
1.500.721.400.360.480.04
EPS (Diluted)
1.500.721.400.360.480.04
EPS Growth
105.27%-48.57%284.30%-23.88%1240.62%-95.15%
Free Cash Flow
80.9334.51138.29290.47108.1-24.29
Free Cash Flow Per Share
0.320.140.541.130.42-0.10
Dividend Per Share
0.6500.3500.4290.2140.2140.071
Dividend Growth
51.66%-18.34%100.00%-200.14%-66.68%
Gross Margin
55.26%53.30%57.68%55.48%56.60%59.99%
Operating Margin
6.57%5.67%10.29%5.32%2.62%3.53%
Profit Margin
29.25%13.81%31.38%8.16%11.18%0.76%
Free Cash Flow Margin
6.13%2.58%11.99%25.33%9.90%-2.13%
EBITDA
171.54152.69185.03126.2587.94103.77
EBITDA Margin
13.00%11.43%16.05%11.01%8.05%9.10%
D&A For EBITDA
84.8676.9666.4365.259.2863.48
EBIT
86.6875.72118.661.0528.6640.29
EBIT Margin
6.57%5.67%10.29%5.32%2.62%3.53%
Effective Tax Rate
12.31%13.89%13.89%20.92%10.95%72.15%
Revenue as Reported
1,3201,3361,1531,1471,0921,141
Advertising Expenses
-266.99253.43264.36283.37351.53
Source: S&P Global Market Intelligence. Standard template. Financial Sources.